CHIP controls necroptosis through ubiquitylation-and lysosome-dependent degradation of RIPK3

Nature Cell Biology

Volumn 18, Issue 3, 2016, Pages 291-302

  Seo, Jinho ^a   Lee, Eun Woo ^a   Sung, Hyerim ^b   Seong, Daehyeon ^a   Dondelinger, Yves ^c,d   Shin, Jihye ^a   Jeong, Manhyung ^b   Lee, Hae Kyung ^a   Kim, Jung Hoon ^a   Han, Su Yeon ^a   Lee, Cheolju ^e   Seong, Je Kyung ^b   Vandenabeele, Peter ^c,d   Song, Jaewhan ^a  

^a Yonsei University   (South Korea)

^b Seoul National University   (South Korea)

^c GHENT UNIVERSITY   (Belgium)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^e Korea Institute of Science and Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYL TERMINUS OF HSP70 INTERACTING PROTEIN; PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN KINASE 1; RECEPTOR INTERACTING PROTEIN KINASE 3; TUMOR NECROSIS FACTOR; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; CHIP PROTEIN, MOUSE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK1 PROTEIN, HUMAN; RIPK3 PROTEIN, HUMAN; STUB1 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DWARFISM; FIBROBLAST; HT 29 CELL LINE; HUMAN; HUMAN CELL; INFLAMMATION; L929 CELL LINE; LIFESPAN; LYSOSOME; MOUSE; NECROPTOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SMALL INTESTINE; THYMUS; UBIQUITINATION; ANIMAL; APOPTOSIS; KNOCKOUT MOUSE; METABOLISM; NECROSIS; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; HUMANS; INFLAMMATION; LYSOSOMES; MICE, KNOCKOUT; NECROSIS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84959241995     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb3314     Document Type: Article

References (59)

1. Vanden Berghe, T., Linkermann, A., Jouan-Lanhouet, S., Walczak, H., Vandenabeele, P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat. Rev. Mol. Cell Biol. 15, 135-147 (2014).
2. Galluzzi, L. et al. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ. 22, 58-73 (2015).
3. Mocarski, E. S., Kaiser, W. J., Livingston-Rosanoff, D., Upton, J. W., Daley-Bauer, L. P. True grit: programmed necrosis in antiviral host defense, inflammation, and immunogenicity. J. Immunol. 192, 2019-2026 (2014).
4. Linkermann, A., Green, D. R. Necroptosis. N. Engl. J. Med. 370, 455-465 (2014).
5. Murphy, J. M., Silke, J. Ars Moriendi; the art of dying well-new insights into the molecular pathways of necroptotic cell death. EMBO Rep. 15, 155-164 (2014).
6. Cho, Y. S. et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137, 1112-1123 (2009).
7. He, S. et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-. Cell 137, 1100-1111 (2009).
8. Zhang, D. W. et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325, 332-336 (2009).
9. Sun, L. et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148, 213-227 (2012).
10. Murphy, J. M. et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 39, 443-453 (2013).
11. Wu, J. et al. Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis. Cell Res. 23, 994-1006 (2013).
12. Remijsen, Q. et al. Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis. Cell Death Dis. 5, e1004 (2014).
13. Li, J. et al. The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 150, 339-350 (2012).
14. Dondelinger, Y. et al. MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep. 7, 971-981 (2014).
15. Wang, H. et al. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol. Cell 54, 133-146 (2014).
16. Cai, Z. et al. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat. Cell Biol. 16, 55-65 (2014).
17. Chen, X. et al. Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res. 24, 105-121 (2014).
18. Wu, X. N. et al. Distinct roles of RIP1-RIP3 hetero-and RIP3-RIP3 homo-interaction in mediating necroptosis. Cell Death Differ. 21, 1709-1720 (2014).
19. Cook, W. D. et al. RIPK1-and RIPK3-induced cell death mode is determined by target availability. Cell Death Differ. 21, 1600-1612 (2014).
20. Chen, W. et al. Ppm1b negatively regulates necroptosis through dephosphorylating Rip3. Nat. Cell Biol. 17, 434-444 (2015).
21. Ahmed, S. F. et al. The chaperone-assisted E3 ligase C terminus of Hsc70-interacting protein (CHIP) targets PTEN for proteasomal degradation. J. Biol. Chem. 287, 15996-16006 (2012).
22. Esser, C., Scheffner, M., Hohfeld, J. The chaperone-associated ubiquitin ligase CHIP is able to target p53 for proteasomal degradation. J. Biol. Chem. 280, 27443-27448 (2005).
23. Ko, H. R. et al. P42 Ebp1 regulates the proteasomal degradation of the p85 regulatory subunit of PI3K by recruiting a chaperone-E3 ligase complex HSP70/CHIP. Cell Death Dis. 5, e1131 (2014).
24. Lee, E. W., Seo, J., Jeong, M., Lee, S., Song, J. The roles of FADD in extrinsic apoptosis and necroptosis. BMB Rep. 45, 496-508 (2012).
25. Vanden Berghe, T., Kalai, M., van Loo, G., Declercq, W., Vandenabeele, P. Disruption of HSP90 function reverts tumor necrosis factor-induced necrosis to apoptosis. J. Biol. Chem. 278, 5622-5629 (2003).
26. Park, S. Y., Shim, J. H., Cho, Y. S. Distinctive roles of receptor-interacting protein kinases 1 and 3 in caspase-independent cell death of L929. Cell Biochem. Funct. 32, 62-69 (2014).
27. Petrucelli, L. et al. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum. Mol. Genet. 13, 703-714 (2004).
28. Mollah, S. et al. Targeted mass spectrometric strategy for global mapping of ubiquitination on proteins. Rapid Commun. Mass Spectrom. 21, 3357-3364 (2007).
29. Kim, W. et al. Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol. Cell 44, 325-340 (2011).
30. Sahara, N. et al. In vivo evidence of CHIP up-regulation attenuating tau aggregation. J. Neurochem. 94, 1254-1263 (2005).
31. Gunther, C. et al. Caspase-8 regulates TNF-induced epithelial necroptosis and terminal ileitis. Nature 477, 335-339 (2011).
32. Kaiser, W. J. et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471, 368-372 (2011).
33. Oberst, A. et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471, 363-367 (2011).
34. Welz, P. S. et al. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 477, 330-334 (2011).
35. Zhang, H. et al. Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 471, 373-376 (2011).
36. Dillon, C. P. et al. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 157, 1189-1202 (2014).
37. Newton, K. et al. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science 343, 1357-1360 (2014).
38. Rickard, J. A. et al. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 157, 1175-1188 (2014).
39. Dannappel, M. et al. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature 513, 90-94 (2014).
40. Takahashi, N. et al. RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis. Nature 513, 95-99 (2014).
41. Mandal, P. et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol. Cell 56, 481-495 (2014).
42. Orozco, S. et al. RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis. Cell Death Differ. 21, 1511-1521 (2014).
43. Duprez, L. et al. RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity 35, 908-918 (2011).
44. Onizawa, M. et al. The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis. Nat. Immunol. 16, 618-627 (2015).
45. Petersen, S. L. et al. TRAF2 is a biologically important necroptosis suppressor. Cell Death Differ. 22, 1846-1857 (2015).
46. Kang, T. B., Yang, S. H., Toth, B., Kovalenko, A., Wallach, D. Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. Immunity 38, 27-40 (2013).
47. Lawlor, K. E. et al. RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL. Nat. Commun. 6, 6282 (2015).
48. Vince, J. E. et al. Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity 36, 215-227 (2012).
49. Moriwaki, K. et al. The Necroptosis Adaptor RIPK3 promotes injury-induced cytokine expression and tissue repair. Immunity 41, 567-578 (2014).
50. Humphries, F., Yang, S., Wang, B., Moynagh, P. N. RIP kinases: key decision makers in cell death and innate immunity. Cell Death Differ. 22, 225-236 (2015).
51. Silke, J., Rickard, J. A., Gerlic, M. The diverse role of RIP kinases in necroptosis and inflammation. Nat. Immunol. 16, 689-697 (2015).
52. Min, J. N. et al. CHIP deficiency decreases longevity, with accelerated aging phenotypes accompanied by altered protein quality control. Mol. Cell. Biol. 28, 4018-4025 (2008).
53. Vanden Berghe, T. et al. Passenger mutations confound interpretation of all genetically modified congenic mice. Immunity 43, 200-209 (2015).
54. Schisler, J. C. et al. CHIP protects against cardiac pressure overload through regulation of AMPK. J. Clin. Invest. 123, 3588-3599 (2013).
55. Lee, I. H. et al. Ahnak functions as a tumor suppressor via modulation of TGF-/Smad signaling pathway. Oncogene 33, 4675-4684 (2014).
56. Oh, W. et al. PML-IV functions as a negative regulator of telomerase by interacting with TERT. J Cell Sci. 122, 2613-2622 (2009).
57. Lee, E. W. et al. USP11-dependent selective cIAP2 deubiquitylation and stabilization determine sensitivity to Smac mimetics. Cell Death Differ. 22, 1463-1476 (2015).
58. Lee, E. W. et al. Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis. EMBO J. 28, 2100-2113 (2009).
59. Lee, E. W. et al. Ubiquitination and degradation of the FADD adaptor protein regulate death receptor-mediated apoptosis and necroptosis. Nat. Commun. 3, 978 (2012).